Charles Woler

Formerly CEO, Hoffman la Roche, France and Chairman European Pharmaceuticals, Smithkline Beecham

Charles has spent some 30 years in the healthcare industry, both in large pharmaceutical companies, SMEs and increasingly in smaller, earlier stage companies. His experience encompasses prescription drugs, OTC, diagnostics and biotech.

Following senior positions at Warner Lambert and Akzo Pharma, he became General Manager, France, of Roche, and then Chairman of Smithkline Beecham's European pharmaceutical business. He then moved into running and developing SMEs, including Bouchara, a French family-owned pharmaceuticals company, CADUS Pharmaceuticals, a NASDAQ-listed biotech company, and Neuro3d, a VC backed biopharmaceutical company. He is currently CEO of Endotis, a speciality pharma company.

Charles is a medical Doctor and holds a Masters in Clinical Pharmacology and Pharmacokinetics, a PhD in Clinical Pharmacology and Methodology and an MBA.

Charles Woler

Charles Woler, Operating Partner

"When I joined Duke Street I became part of a team of Operating Partners with extensive experience and knowledge of a wide range of sectors. Our motivation for working with the Duke Street companies is to stay in the loop, lending our operational experience to the investment and management teams. Because we stay in close touch, increasingly this means we can share best practice across the sectors that Duke Street is working in."

Related Sectors

Related Case Studies